The growing use of GLP-1 receptor agonists may affect the interpretation of oncological FDG PET-CT scans, new research presented today at the 38th Annual Congress of the European Association of Nuclear Medicine (EANM 2025) has revealed.
from Medical Xpress - latest medical and health news stories https://ift.tt/XUshoqw
